Pentostatin (Nipent) in T-cell malignancies

Seminars in Oncology

Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 52-57

  Ho, A D ^a   Suciu, S ^a   Stryckmans, P ^a   De Cataldo, F ^a   Willemze, R ^a   Thaler, J ^a   Peetermans, M ^a   Dohner, H ^a   Solbu, G ^a   Dardenne, M ^a   Zittoun, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOSTATIN;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; INFECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS FUNGOIDES; NAUSEA; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEZARY SYNDROME; T CELL LEUKEMIA; T CELL LYMPHOMA; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CAUSE OF DEATH; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, HAIRY CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, PROLYMPHOCYTIC; LEUKEMIA, T-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PENTOSTATIN; REMISSION INDUCTION; SEZARY SYNDROME; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0033933650     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)